BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

North America

Ascentage Pharma Gets FDA Clearance for Global Phase III Trial of Lisaftoclax in CLL/SLL Patients

Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related...

August 07, 2023 | News

BioPharma America | Elevating Insights, Enabling Progress: Navigating BioPharma Excellence at Your Fingertips

Unveiling the Future of Pharma and Biotech: Explore Insights, Innovations, and Breakthroughs on BioPharma America – Your Premier Media Destination fo...

August 05, 2023 | News

US FDA Grants Orphan Drug Status to ABM-1310 for BRAF V600 Glioblastoma

Orphan Drug Designation is a significant recognition bestowed by the FDA to the drugs used in the treatment of rare diseases. This designation intends to e...

August 03, 2023 | News

FDA Clears Terumo's Reveos® Automated Whole Blood Processing System for U.S. Commercial Use

Terumo Blood and Cell Technologies (Terumo BCT) announces U.S. Food and Drug Administration (FDA) clearance of the Reveos Automated Whole Blood Processing ...

August 02, 2023 | News

Lupin Pharmaceuticals Recalls 2 Lots of TydemyTM Due to OOS Results

Lupin Pharmaceuticals Inc. (Lupin) is voluntarily recalling two (2) lots of Tydemy (Drospirenone, Ethinyl Estradiol and Levomefolate Calcium Tablets 3mg/0....

July 31, 2023 | News

MSD and Moderna Launch Phase 3 Study for Melanoma Treatment

“As we continue our efforts to advance novel treatment options for patients with high-risk Stage IIB-IV melanoma, the initiation of the V940-001 Phas...

July 28, 2023 | News

BioMap unveils a “Life Science Leaderboard” to compare AI models

Highlights: New AI leaderboard provides comparison of 25+ of the most important, representative and cutting-edge tasks across six distinct...

July 26, 2023 | News

Alma Veil™ Launched for U.S. Market by Sisram Medical's Alma

Alma Veil is the core instrument equipped with three gold-standard technologies conveniently integrated into a single handpiece: 532 nm laser:...

July 26, 2023 | News

Insilico Medicine Nominates Preclinical Candidate for ISM001-055, First Generative AI IPF Drug

Insilico Medicine merges nebulizer device with AI-driven drug discovery; Potential advantages for the inhalation solution include a smaller effe...

July 24, 2023 | News

Sartorius completes acquisition of Polyplus

Polyplus is a leading provider of innovative technologies for cell and gene therapies. Transfection reagents developed and produced by Polyplus are key com...

July 18, 2023 | News

Scribe Therapeutics and Sanofi Team Up to Advance In Vivo Genetic Medicines for Sickle Cell and Genomic Disease

Predicated on the progress of the companies’ first collaboration, Sanofi has selected Scribe’s novel CRISPR by Design™ approach to driv...

July 18, 2023 | News

Antengene Administers First Patient in US Clinical Study of ATG-017 for Advanced Solid Tumors with Nivolumab Combination

- ATG-017 is an oral, potent and selective small molecule ERK1/2 inhibitor. Antengene has exclusive global rights to develop...

July 18, 2023 | News

VitaDAO Launches VITA-FAST Tokens, Revolutionizing Governance in Longevity Research

The VITA-FAST tokens, which allow holders to make decisions on IP licensing, set experiment priorities, and govern research on autophagy, have been met wit...

July 11, 2023 | News

Innovent and IASO Bio Receive NMPA Approval for FUCASO®, a Fully-human BCMA CAR-T Therapy for Multiple Myeloma

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality me...

July 03, 2023 | News

Stay Connected